In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Uncertain Reg Climate Could Turn Medtech Investors Off Europe

Executive Summary

A key stage in the EU process of adopting and implementing new regulations for medical devices and diagnostics was reached with the recent series of debates – the Trilogues – between the European Commission, the Parliament and Council of the EU. But matters are poised on a knife edge and are not always moving as quickly as or in the way local industry wants.

Advertisement

Related Content

European IVD Companies See Worrying Trend In Market Access Barriers
IVD Companies Brace For EU Regulatory Changes

Topics

UsernamePublicRestriction

Register

IV004461

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel